KOVACHKA, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 281
EU - Europa 229
AS - Asia 125
SA - Sud America 7
AF - Africa 4
OC - Oceania 2
Totale 648
Nazione #
US - Stati Uniti d'America 277
IT - Italia 98
IE - Irlanda 39
CN - Cina 38
SG - Singapore 37
GB - Regno Unito 20
SE - Svezia 18
IN - India 14
HK - Hong Kong 13
FR - Francia 11
DE - Germania 9
UA - Ucraina 8
ID - Indonesia 5
JP - Giappone 5
AR - Argentina 4
FI - Finlandia 4
NG - Nigeria 4
CH - Svizzera 3
DK - Danimarca 3
ES - Italia 3
KR - Corea 3
NO - Norvegia 3
VN - Vietnam 3
AM - Armenia 2
CA - Canada 2
CL - Cile 2
CZ - Repubblica Ceca 2
MX - Messico 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
RU - Federazione Russa 2
AT - Austria 1
AU - Australia 1
BE - Belgio 1
BO - Bolivia 1
IL - Israele 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 648
Città #
Los Angeles 54
Dublin 39
Turin 39
Chandler 34
Singapore 31
Ashburn 18
Fairfield 11
Nyköping 11
Central 7
Milan 7
Bradford 6
Boardman 5
Jakarta 5
Leeds 5
Paris 5
Princeton 5
Rome 5
Torino 5
Abuja 4
Crescentino 4
Hangzhou 4
Philadelphia 4
Santa Clara 4
Seattle 4
Suzhou 4
Zola Predosa 4
Barcelona 3
Bari 3
Birmingham 3
Boston 3
Chengdu 3
Copenhagen 3
Guangzhou 3
Herne 3
Kyiv 3
Lappeenranta 3
London 3
Palermo 3
Pune 3
Skien 3
Skipton 3
Woburn 3
Beijing 2
Bloomington 2
Brooklyn 2
Buenos Aires 2
Carrara 2
Chandigarh 2
Clifton 2
College Station 2
Corvallis 2
Doha 2
Dong Ket 2
Lausanne 2
Lisbon 2
Liupanshui 2
Medford 2
Nanjing 2
Novi Sad 2
Nowon-gu 2
Osaka 2
Parma 2
Reston 2
Roubaix 2
Royersford 2
Talca 2
Tianjin 2
Wanchai 2
Woodbridge 2
Yerevan 2
Alessandria 1
Auckland 1
Bangalore 1
Bangkok 1
Berlin 1
Bologna 1
Brunflo 1
Cambridge 1
Charlotte 1
Ecatepec 1
Frankfurt am Main 1
Gattatico 1
Genoa 1
Heidelberg 1
Helsinki 1
Herzliya 1
Ho Chi Minh City 1
Hradec Králové 1
Humpolec 1
Jacksonville 1
Junín 1
Kanazawa 1
Kannur 1
Keystone Heights 1
La Louvière 1
Luzhou 1
Melbourne 1
Mumbai 1
Newton 1
Nice 1
Totale 458
Nome #
New aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the hydroxytriazole scaffold 139
New inhibitors of Aldo-Keto Reductase 1C3 (AKR1C3) based on benzoisoxazole scaffold and their potential application in cancer 115
Iron metabolism at the interface between host and pathogen: From nutritional immunity to antibacterial development 88
Multiple-targeting ligands for AKR1C3 enzyme and androgen receptor to target prostate cancer 59
A community effort in SARS-CoV-2 drug discovery 57
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein 48
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 39
Application of an in house bioisosteric approach to the design of innovative inhibitors of aldo-keto reductase 1C3 (AKR1C3) 36
HYDROXYLATED HETEROCYCLES AS BIOISOSTERES OF THE CARBOXYLIC FUNCTION: DESIGN OF NEW AKR1C3 INHIBITORS ACTIVE IN PROSTATE CANCER 28
Application of an in house bioisosteric approach to the design of innovative inhibitors of aldo-keto reductase 1C3 (AKR1C3) 25
Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer 23
NEW AKR1C3 INHIBITORS WITH BENZOISOXAZOLE CORE: DESIGN, SYNTHESIS AND BIOLOGICAL ACTIVITY TO TARGET PROSTATE CANCER 10
Totale 667
Categoria #
all - tutte 3.310
article - articoli 0
book - libri 0
conference - conferenze 1.599
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.909


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 0 0 2 4 3
2020/202129 0 4 4 0 4 2 2 4 1 2 0 6
2021/202263 0 0 1 1 3 1 1 2 1 12 25 16
2022/2023208 14 13 7 23 15 63 18 4 14 10 4 23
2023/2024266 26 16 19 12 23 19 53 20 1 13 23 41
2024/202592 21 39 25 7 0 0 0 0 0 0 0 0
Totale 667